Fig. 3.

Changes in EAPP from baseline to month 6 and to month 24 among all patients included in efficacy analysis set (a) and according to type of diagnosis (b) and baseline EAPP severity (c). Data shown are proportions of patients with deterioration, no change and improvement defined as > 0, 0 and < 0 difference in EAPP scores between baseline and visits at months 6 and 24. *Including patients with surgical diagnosis only and surgical and clinical diagnosis. **0.3% of patients each had no change, improvement or missing data on change of EAPP. EAPP, endometriosis-associated pelvic pain